FOR IMMEDIATE RELEASE
ACS News Service Weekly PressPac: October 13, 2021
Warm milk makes you sleepy � peptides could explain why
Journal of Agricultural and Food Chemistry
According to time-honored advice, drinking a glass of warm milk at bedtime will encourage a good night’s rest. Milk’s sleep-enhancing properties are commonly ascribed to tryptophan, but scientists have also discovered a mixture of milk peptides, called casein tryptic hydrolysate (CTH), that relieves stress and enhances sleep. Now, researchers reporting in ACS’Ì�Journal of Agricultural and Food ChemistryÌýhave identified specific peptides in CTH that might someday be used in new, natural sleep remedies.
According to the U.S. Centers for Disease Control and Prevention, one-third of U.S. adults don’t get enough sleep. Sedatives, such as benzodiazepines and zolpidem, are commonly prescribed for insomnia, but they can cause side effects, and people can become addicted to them. Many sedatives work by activating the GABA receptor, a protein in the brain that suppresses nerve signaling. Scientists have also discovered several natural peptides, or small pieces of proteins, that bind the GABA receptor and have anti-anxiety and sleep-enhancing effects. For example, treating a protein in cow’s milk, called casein, with the digestive enzyme trypsin produces the mixture of sleep-enhancing peptides known as CTH. Within this mixture, a specific peptide known as α-casozepine (α-CZP) has been identified that could be responsible for some of these effects. Lin Zheng, Mouming Zhao and colleagues wondered if they could find other, perhaps more powerful, sleep-enhancing peptides in CTH.
The researchers first compared the effects of CTH and α-CZP in mouse sleep tests, finding that CTH showed better sleep-enhancing properties than α-CZP alone. This result suggested that other sleep-promoting peptides besides α-CZP exist in CTH. The team then used mass spectrometry to identify bioactive peptides released from CTH during simulated gastric digestion, and they virtually screened these peptides for binding to the GABA receptor and for the ability to cross the blood-brain barrier. When the strongest candidates were tested in mice, the best one (called YPVEPF) increased the number of mice that fell asleep quickly by about 25% and the sleep duration by more than 400% compared to a control group. In addition to this promising peptide, others in CTH should be explored that might enhance sleep through other pathways, the researchers say.Ìý
The authors acknowledge funding from theÌý, the Guangdong Provincial Key R&D Program, the Shandong Provincial Key R&D Program, and the Specific Fund Program for Basic and Applied Basic Research of Guangdong Province.
Ìý
###
The American Chemical Öйú365betÖÐÎĹÙÍø (ACS) is a nonprofit organization founded in 1876 and chartered by the U.S. Congress. ACS is committed to improving all lives through the transforming power of chemistry. Its mission is to advance scientific knowledge, empower a global community and champion scientific integrity, and its vision is a world built on science. The Öйú365betÖÐÎĹÙÍø is a global leader in promoting excellence in science education and providing access to chemistry-related information and research through its multiple research solutions, peer-reviewed journals, scientific conferences, e-books and weekly news periodicalÌýChemical & Engineering News. ACS journals are among the most cited, most trusted and most read within the scientific literature; however, ACS itself does not conduct chemical research. As a leader in scientific information solutions, its CAS division partners with global innovators to accelerate breakthroughs by curating, connecting and analyzing the world’s scientific knowledge. ACSâ€� main offices are in Washington, D.C., and Columbus, Ohio.
Registered journalists can subscribe to the to access embargoed and public science press releases. For media inquiries, contact newsroom@acs.org.
Note: ACS does not conduct research but publishes and publicizes peer-reviewed scientific studies.
Media Contact
ACS Newsroom
newsroom@acs.org
###
La sociedad American Chemical Öйú365betÖÐÎĹÙÍø (ACS) es una organización sin fines de lucro fundada en 1876 y aprobada por el Congreso de los Estados Unidos. La ACS se ha comprometido a mejorar la vida de todas las personas mediante la transformación del poder de la quÃmica. Su misión es promover el conocimiento cientÃfico, empoderar a la comunidad global y defender la integridad cientÃfica, y su visión es un mundo construido basándose en la ciencia. La Sociedad es lÃder mundial en la promoción de la excelencia en la educación cientÃfica y en el acceso a información e investigación relacionadas con la quÃmica a través de sus múltiples soluciones de investigación, publicaciones revisadas por expertos, conferencias cientÃficas, libros electrónicos y noticias semanales periódicas de Chemical & Engineering News. Las revistas de la ACS se encuentran entre las más citadas, las más fiables y las más leÃdas en la literatura cientÃfica; sin embargo, la propia ACS no realiza investigación quÃmica. Como lÃder en soluciones de información cientÃfica, su división CAS se asocia con innovadores internacionales para acelerar los avances mediante la preservación, la conexión y el análisis de los conocimientos cientÃficos del mundo. Las sedes principales de la ACS se encuentran en Washington, D.C., y Columbus, Ohio.
Los periodistas registrados pueden suscribirse al en EurekAlert! para acceder a comunicados de prensa públicos y retenidos.Ìý Para consultas de los medios, comunÃquese con newsroom@acs.org.
Nota: ACS no realiza investigaciones, pero publica y divulga estudios cientÃficos revisados por expertos.â€�
;void(0);){kind=link}